Carolyn Barber, MD on Nostr: NEW: The FDA has authorized a new monoclonal anitbody, Pemgarda, to protect ...

NEW: The FDA has authorized a new monoclonal anitbody, Pemgarda, to protect immunocompromised individuals (like transplant recipients & those with heme malignancies). against Covid-19. Immunocomp individuals have a higher risk of severe outcomes.

https://www.statnews.com/2024/03/22/covid-immunocompromised-antibody-protection-invivyd/
#COVID #COVID19 #monoclonal #medtwitter